Tag Archives: sorafenib

Bayer Vs Controller of patents

[SpicyIP] [Order] Yesterday, a interesting news is posted in SpicyIP blog.  Bayer challenges ambiguity in statutory language of “prima facie case” of section 87(1). Controller has published Natco’s compulsory license as per section 87(1) as prima facie case made out (published on Aug 12th … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | 1 Comment

Breach of agreement-Onyx Vs Bayer-Sorafenib derivative

This is about breach of contract/collaborative agreement between onyx and bayer. [Press release] Recently Onyx and Bayer announced settlement agreement regarding the drug called “Regorafenib”(BAY73-4506). Regorafenib is structurally similar to sorafenib except a Fluoro substitution on sorafenib moiety. Sorafenib Regorafenib … Continue reading

Posted in Drug developments & targets | Tagged , , , | Leave a comment